IntreTech: Expansion into E-Cigarette Electronic Screen Business

Business by 2FIRSTS.ai

Jun.28.2024

IntreTech: Expansion into E-Cigarette Electronic Screen Business

IntreTech (002925.SZ) responds to investor queries, confirming involvement in e-cigarette electronic screen business, shifting focus to fourth generation products.

Recently, an investor asked IntreTech (002925.SZ) on the investor interaction platform: Does your company have any products related to the e-cigarette electronic screen business?

In response, IntreTech stated that the company mainly provides e-cigarette devices and components to clients.

IntreTech recently stated in response to investor inquiries that the main reason for their revenue decline is due to the shift from third-generation e-cigarette products to fourth-generation products as part of their clients' development strategies. The company's income from supplying plastic components for third-generation products has decreased. However, IntreTech's core components and complete machines for fourth-generation products have successfully entered mass production and sales, further establishing their "parts + components + complete machines" business system.

It is reported that in 2014, IntreTech entered into a partnership with Philip Morris International (PMI) to supply the HNB tobacco brand IQOS tobacco heating devices. Since then, IntreTech has become a supplier of precision plastic components for the devices.

References:

[1] 贵司有产品涉及电子烟电子屏相关业务吗？

Also Read:

[1] IQOS Supplier IntreTech Saw Decline in E-Cigarette Revenue by 2023

[2] IntreTech Plans E-Cigarette Mass Production in 3rd Quarter

[3] IQOS Device Maker IntreTech Releases 2023 Semi-Annual Report

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | OXVA launches Artio 2 liquid-tobacco pod device, positioned as distinct from HNB and traditional flavored e-cigarettes

OXVA has released its Artio 2 pod device featuring the Liquid Tobacco Intelligent (LTI) platform. It offers around 400 puffs per charge, pods equivalent to about 35 cigarettes, five tobacco and shisha flavors, and a 900mAh battery with 30-minute fast charging. The company positions the device as distinct from HNB and traditional flavored e-cigarettes.

Nov.27 by 2FIRSTS.ai

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

California DOJ Outlines Next Steps for Unflavored Tobacco List; Enforcement to Target “Obviously Flavored” Products

The California DOJ issued Information Bulletin No. 2025-DLE-17 on November 10, 2025, providing an update on the state’s flavored tobacco enforcement. The Attorney General’s office is set to launch the Unflavored Tobacco List (UTL) by December 31, 2025, identifying tobacco products without characterizing flavors that may legally be sold in California. Enforcement will continue to focus on “obviously flavored” products, while unregistered products remain subject to seizure and penalties.

Nov.17 by 2FIRSTS.ai

KT&G Q3 Net Profit Up 73%; Overseas NGP Revenue Nearly Doubles, Nicotine Pouch Expansion Set to Launch Globally

KT&G reported its Q3 2025 financial results, posting revenue of KRW 1.83 trillion (≈USD 1.31 billion) and a 73.4% year-over-year surge in net profit—marking the company’s highest operating profit in five years. The Next Generation Product (NGP) segment performed strongly, generating KRW 279.1 billion (≈USD 199 million) in revenue, with overseas NGP sales more than doubling year-over-year.